Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study
Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults. We tested 23 serum BA species in...
Saved in:
Published in | Diabetes care Vol. 44; no. 2; pp. 499 - 510 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Diabetes Association
01.02.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 0149-5992 1935-5548 1935-5548 |
DOI | 10.2337/dc20-0884 |
Cover
Abstract | Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults.
We tested 23 serum BA species in subjects with incident diabetes (
= 1,707) and control subjects (
= 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression.
In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid (
< 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset.
These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes. |
---|---|
AbstractList | Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults.OBJECTIVEComprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults.We tested 23 serum BA species in subjects with incident diabetes (n = 1,707) and control subjects (n = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression.RESEARCH DESIGN AND METHODSWe tested 23 serum BA species in subjects with incident diabetes (n = 1,707) and control subjects (n = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression.In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid (P < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset.RESULTSIn multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid (P < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset.These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes.CONCLUSIONSThese findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes. OBJECTIVE Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults. RESEARCH DESIGN AND METHODS We tested 23 serum BA species in subjects with incident diabetes (n = 1,707) and control subjects (n = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression. RESULTS In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83–0.96) for cholic acid, 0.90 (0.84–0.97) for chenodeoxycholic acid, and 0.90 (0.83–0.96) for deoxycholic acid (P < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset. CONCLUSIONS These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes. Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and coregulation with the risk of developing type 2 diabetes mellitus (T2DM) among normoglycemic Chinese adults. We tested 23 serum BA species in subjects with incident diabetes ( = 1,707) and control subjects ( = 1,707) matched by propensity score (including age, sex, BMI, and fasting glucose) from the China Cardiometabolic Disease and Cancer Cohort (4C) Study, which was composed of 54,807 normoglycemic Chinese adults with a median follow-up of 3.03 years. Multivariable-adjusted odds ratios (ORs) for associations of BAs with T2DM were estimated using conditional logistic regression. In multivariable-adjusted logistic regression analysis, per SD increment of unconjugated primary and secondary BAs were inversely associated with incident diabetes, with an OR (95% CI) of 0.89 (0.83-0.96) for cholic acid, 0.90 (0.84-0.97) for chenodeoxycholic acid, and 0.90 (0.83-0.96) for deoxycholic acid ( < 0.05 and false discovery rate <0.05). On the other hand, conjugated primary BAs (glycocholic acid, taurocholic acid, glycochenodeoxycholic acid, taurochenodeoxycholic acid, and sulfated glycochenodeoxycholic acid) and secondary BA (tauroursodeoxycholic acid) were positively related with incident diabetes, with ORs ranging from 1.11 to 1.19 (95% CIs ranging between 1.05 and 1.28). In a fully adjusted model additionally adjusted for liver enzymes, HDL cholesterol, diet, 2-h postload glucose, HOMA-insulin resistance, and waist circumference, the risk estimates were similar. Differential correlation network analysis revealed that perturbations in intraclass (i.e., primary and secondary) and interclass (i.e., unconjugated and conjugated) BA coregulation preexisted before diabetes onset. These findings reveal novel changes in BAs exist before incident T2DM and support a potential role of BA metabolism in the pathogenesis of diabetes. |
Author | Zheng, Ruizhi Tang, Xulei Liu, Chao Yang, Tao Xu, Min Lu, Jieli Wan, Qin Chen, Li Huo, Yanan Wang, Tiange Chen, Lulu Wang, Xiaolin Qin, Guijun Zhang, Yinfei Deng, Huacong Zhao, Xinjie Shen, Feixia Du, Rui Wang, Shuangyuan Bi, Yufang Liu, Ruixin Ye, Zhen Luo, Zuojie Dai, Meng Wang, Youmin Zhao, Jiajun Li, Qi Lai, Shenghan Wu, Shengli Zhang, Yi Hu, Ruying Wang, Guixia Zhao, Zhiyun Chen, Gang Wang, Jiqiu Chen, Yuhong Li, Donghui Shi, Lixin Su, Qing Zhang, Di Xu, Guowang Ning, Guang Xu, Yu Yan, Li Hu, Chunyan Wang, Weiqing Li, Qiang Gao, Zhengnan Qin, Yingfen Mu, Yiming Yu, Xuefeng Li, Mian |
Author_xml | – sequence: 1 givenname: Jieli orcidid: 0000-0003-1317-0896 surname: Lu fullname: Lu, Jieli organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 2 givenname: Shuangyuan surname: Wang fullname: Wang, Shuangyuan organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 3 givenname: Mian surname: Li fullname: Li, Mian organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 4 givenname: Zhengnan surname: Gao fullname: Gao, Zhengnan organization: Dalian Municipal Central Hospital, Dalian, China – sequence: 5 givenname: Yu surname: Xu fullname: Xu, Yu organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 6 givenname: Xinjie surname: Zhao fullname: Zhao, Xinjie organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China – sequence: 7 givenname: Chunyan orcidid: 0000-0002-8673-3859 surname: Hu fullname: Hu, Chunyan organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 8 givenname: Yi surname: Zhang fullname: Zhang, Yi organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 9 givenname: Ruixin surname: Liu fullname: Liu, Ruixin organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 10 givenname: Ruying surname: Hu fullname: Hu, Ruying organization: Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China – sequence: 11 givenname: Lixin surname: Shi fullname: Shi, Lixin organization: Affiliated Hospital of Guiyang Medical College, Guiyang, China – sequence: 12 givenname: Ruizhi surname: Zheng fullname: Zheng, Ruizhi organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 13 givenname: Rui orcidid: 0000-0003-3736-7909 surname: Du fullname: Du, Rui organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 14 givenname: Qing surname: Su fullname: Su, Qing organization: Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China – sequence: 15 givenname: Jiqiu surname: Wang fullname: Wang, Jiqiu organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 16 givenname: Yuhong surname: Chen fullname: Chen, Yuhong organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 17 givenname: Xuefeng orcidid: 0000-0003-3961-9321 surname: Yu fullname: Yu, Xuefeng organization: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China – sequence: 18 givenname: Li surname: Yan fullname: Yan, Li organization: Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China – sequence: 19 givenname: Tiange orcidid: 0000-0003-0723-489X surname: Wang fullname: Wang, Tiange organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 20 givenname: Zhiyun surname: Zhao fullname: Zhao, Zhiyun organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 21 givenname: Xiaolin surname: Wang fullname: Wang, Xiaolin organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China – sequence: 22 givenname: Qi surname: Li fullname: Li, Qi organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China – sequence: 23 givenname: Guijun orcidid: 0000-0002-2503-7534 surname: Qin fullname: Qin, Guijun organization: The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China – sequence: 24 givenname: Qin surname: Wan fullname: Wan, Qin organization: The Affiliated Hospital of Southwest Medical University, Luzhou, China – sequence: 25 givenname: Gang orcidid: 0000-0002-8105-2384 surname: Chen fullname: Chen, Gang organization: Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China – sequence: 26 givenname: Min orcidid: 0000-0003-4464-453X surname: Xu fullname: Xu, Min organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 27 givenname: Meng surname: Dai fullname: Dai, Meng organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 28 givenname: Di surname: Zhang fullname: Zhang, Di organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 29 givenname: Xulei surname: Tang fullname: Tang, Xulei organization: The First Hospital of Lanzhou University, Lanzhou, China – sequence: 30 givenname: Guixia orcidid: 0000-0001-8107-616X surname: Wang fullname: Wang, Guixia organization: The First Hospital of Jilin University, Changchun, China – sequence: 31 givenname: Feixia surname: Shen fullname: Shen, Feixia organization: The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China – sequence: 32 givenname: Zuojie orcidid: 0000-0003-2377-6357 surname: Luo fullname: Luo, Zuojie organization: The First Affiliated Hospital of Guangxi Medical University, Nanning, China – sequence: 33 givenname: Yingfen orcidid: 0000-0002-8456-1678 surname: Qin fullname: Qin, Yingfen organization: The First Affiliated Hospital of Guangxi Medical University, Nanning, China – sequence: 34 givenname: Li orcidid: 0000-0001-7670-8062 surname: Chen fullname: Chen, Li organization: Qilu Hospital of Shandong University, Jinan, China – sequence: 35 givenname: Yanan surname: Huo fullname: Huo, Yanan organization: Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, Nanchang, China – sequence: 36 givenname: Qiang surname: Li fullname: Li, Qiang organization: The Second Affiliated Hospital of Harbin Medical University, Harbin, China – sequence: 37 givenname: Zhen surname: Ye fullname: Ye, Zhen organization: Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China – sequence: 38 givenname: Yinfei surname: Zhang fullname: Zhang, Yinfei organization: Central Hospital of Shanghai Jiading District, Shanghai, China – sequence: 39 givenname: Chao surname: Liu fullname: Liu, Chao organization: Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China – sequence: 40 givenname: Youmin surname: Wang fullname: Wang, Youmin organization: The First Affiliated Hospital of Anhui Medical University, Hefei, China – sequence: 41 givenname: Shengli surname: Wu fullname: Wu, Shengli organization: Karamay Municipal People’s Hospital, Xinjiang, China – sequence: 42 givenname: Tao orcidid: 0000-0001-6375-3622 surname: Yang fullname: Yang, Tao organization: The First Affiliated Hospital of Nanjing Medical University, Nanjing, China – sequence: 43 givenname: Huacong surname: Deng fullname: Deng, Huacong organization: The First Affiliated Hospital of Chongqing Medical University, Chongqing, China – sequence: 44 givenname: Donghui surname: Li fullname: Li, Donghui organization: Department of Gastrointestinal Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX – sequence: 45 givenname: Shenghan surname: Lai fullname: Lai, Shenghan organization: Johns Hopkins University School of Medicine, Baltimore, MD – sequence: 46 givenname: Yiming surname: Mu fullname: Mu, Yiming organization: Chinese People’s Liberation Army General Hospital, Beijing, China – sequence: 47 givenname: Lulu orcidid: 0000-0001-9621-9231 surname: Chen fullname: Chen, Lulu organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China – sequence: 48 givenname: Jiajun orcidid: 0000-0002-7613-1408 surname: Zhao fullname: Zhao, Jiajun organization: Shandong Provincial Hospital affiliated to Shandong University, Jinan, China – sequence: 49 givenname: Guowang orcidid: 0000-0003-4298-3554 surname: Xu fullname: Xu, Guowang organization: Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China – sequence: 50 givenname: Guang orcidid: 0000-0002-5754-7635 surname: Ning fullname: Ning, Guang organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 51 givenname: Yufang orcidid: 0000-0002-4829-5915 surname: Bi fullname: Bi, Yufang organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China – sequence: 52 givenname: Weiqing orcidid: 0000-0001-6027-3084 surname: Wang fullname: Wang, Weiqing organization: Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai National Clinical Research Center for Endocrine and Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33355246$$D View this record in MEDLINE/PubMed |
BookMark | eNplkcFu1DAQhi1URLcLB14AWeICh9A4thOb27LbBaQKKgriGDn2ZNcliRfbAeWB-p443fZSTqPRfP8_o_nP0MngBkDoJcnfFZRW50YXeZYLwZ6gBZGUZ5wzcYIWOWEy41IWp-gshJs8zxkT4hk6pZRyXrBygW5XIThtVbRuwK7F1-DHHn-wHeCVtibgK-_auVODwVcq7v-qCW-m4GE3dkfVTxv3OO4Bf7Ph1-yxgT_QuYMddnhjVQMRAl71LrVfnO_drps09Fbj9d4OENIiM3YxvMdbO5gkCnjrXX_nyNb4Oo5meo6etqoL8OK-LtGP7cX39afs8uvHz-vVZaYpEzFjUhvJNCk4MzmvaA5USgm0AmigVQUlTGhegiQNK9MM2rKqGmPakpRMc6BL9Oboe_Du9wgh1r0NGrpODeDGUBesooyIkoqEvn6E3rjRD-m6RImSSMLTBUv06p4amx5MffC2V36qHwJIwPkR0N6F9NW21jbe_TV6Zbua5PUccT1HXM8RJ8XbR4oH0__Zfwzypo8 |
CitedBy_id | crossref_primary_10_1016_j_jare_2023_11_026 crossref_primary_10_3389_fcimb_2024_1436477 crossref_primary_10_1016_j_jep_2024_118065 crossref_primary_10_1016_j_xcrm_2022_100727 crossref_primary_10_59717_j_xinn_life_2024_100093 crossref_primary_10_1186_s12933_024_02496_5 crossref_primary_10_1155_2022_2391188 crossref_primary_10_3389_fendo_2023_1232132 crossref_primary_10_1016_j_chroma_2024_464827 crossref_primary_10_14336_AD_2022_0817 crossref_primary_10_3389_fnut_2022_930414 crossref_primary_10_1016_j_fbio_2024_104618 crossref_primary_10_3389_fmicb_2022_1029409 crossref_primary_10_3389_fphar_2024_1383896 crossref_primary_10_2147_DMSO_S370492 crossref_primary_10_1038_s41387_024_00315_0 crossref_primary_10_1096_fj_202302558R crossref_primary_10_3390_nu13041104 crossref_primary_10_1016_j_cca_2024_120004 crossref_primary_10_1111_dom_14683 crossref_primary_10_1016_j_jpba_2022_115139 crossref_primary_10_1093_lifemeta_loaf001 crossref_primary_10_3389_fendo_2024_1430720 crossref_primary_10_1016_j_xcrm_2024_101688 crossref_primary_10_1016_j_jff_2024_106600 crossref_primary_10_1016_j_phrs_2023_106983 crossref_primary_10_3390_metabo11120845 crossref_primary_10_12677_ACM_2023_13122796 crossref_primary_10_1016_j_metabol_2022_155312 crossref_primary_10_1186_s13098_024_01558_8 crossref_primary_10_1371_journal_pone_0303569 crossref_primary_10_3389_fendo_2021_754006 crossref_primary_10_3389_fmicb_2024_1373402 crossref_primary_10_1016_j_neucom_2024_128447 crossref_primary_10_3390_metabo11070453 crossref_primary_10_4239_wjd_v14_i3_255 crossref_primary_10_1111_dom_15104 crossref_primary_10_1210_endrev_bnae025 crossref_primary_10_3390_cells10092437 crossref_primary_10_1007_s12020_024_04115_5 crossref_primary_10_3389_fendo_2022_956203 crossref_primary_10_1080_19490976_2025_2474143 crossref_primary_10_1016_j_ajcnut_2023_08_023 crossref_primary_10_1016_j_jlr_2024_100625 crossref_primary_10_1038_s41467_022_30712_x crossref_primary_10_1038_s41574_024_01067_8 crossref_primary_10_1038_s41598_023_50304_z crossref_primary_10_1210_clinem_dgac659 crossref_primary_10_1038_s12276_023_00932_2 crossref_primary_10_1016_j_bcp_2024_116313 crossref_primary_10_1016_j_ajcnut_2024_05_003 crossref_primary_10_2337_dc21_1023 crossref_primary_10_1016_j_foodres_2023_113471 crossref_primary_10_3389_fendo_2021_807318 |
Cites_doi | 10.1038/nm.4358 10.3892/mmr.2016.4761 10.1038/nchembio.1864 10.2337/db13-0639 10.1001/jamacardio.2019.2499 10.2337/dc19-0100 10.1038/nm.2307 10.1016/j.cmet.2016.05.005 10.1007/s12247-014-9182-5 10.1210/jc.2013-3367 10.1111/1753-0407.12858 10.1249/01.MSS.0000078924.61453.FB 10.1111/dom.12648 10.1016/S2213-8587(19)30425-5 10.2337/dc15-2251 10.1002/mnfr.200600162 10.1053/j.gastro.2017.01.055 10.1007/s00125-016-4041-1 10.1038/srep46337 10.1126/science.284.5418.1362 10.1161/CIRCULATIONAHA.109.192703 10.2337/dc18-1390 10.1111/1753-0407.13040 10.1016/j.jacc.2018.09.062 10.1016/S0022-2275(20)38331-0 10.3109/21691401.2015.1069299 10.1111/1753-0407.12108 10.1038/s41467-017-01682-2 10.1371/journal.pgen.1006379 10.1038/nrd2619 10.1016/j.bcp.2013.07.022 10.1038/nrgastro.2017.119 |
ContentType | Journal Article |
Copyright | 2020 by the American Diabetes Association. Copyright American Diabetes Association Feb 1, 2021 |
Copyright_xml | – notice: 2020 by the American Diabetes Association. – notice: Copyright American Diabetes Association Feb 1, 2021 |
CorporateAuthor | 4C Study Group |
CorporateAuthor_xml | – name: 4C Study Group |
DBID | AAYXX CITATION NPM K9. NAPCQ 7X8 |
DOI | 10.2337/dc20-0884 |
DatabaseName | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) ProQuest Nursing and Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1935-5548 |
EndPage | 510 |
ExternalDocumentID | 33355246 10_2337_dc20_0884 |
Genre | Journal Article |
GroupedDBID | --- -ET ..I .XZ 08P 0R~ 18M 29F 2WC 4.4 53G 5GY 5RE 5RS 5VS 6PF 8R4 8R5 AAFWJ AAIKC AAMNW AAWTL AAYEP AAYXX ABOCM ABPPZ ACGFO ACGOD ADBBV AEGXH AENEX AERZD AFOSN AFRAH AHMBA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BENPR BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EMOBN EX3 F5P GX1 H13 HZ~ IAO IEA IHR INH INR IOF IPO KQ8 L7B M0K M5~ O5R O5S O9- OK1 OVD P2P PCD Q2X RHI SV3 TDI TEORI TR2 TWZ VVN W8F WH7 WOQ WOW YHG YOC ZCG ~KM .55 .GJ 3O- 3V. 41~ 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 AAKAS AAQOH AAQQT AAYJJ ABUWG ADZCM AFFNX AFKRA AI. AN0 AQUVI ATCPS AZQEC BCR BCU BEC BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BVXVI C1A CCPQU DWQXO EJD FYUFA GNUQQ GUQSH HCIFZ HMCUK IAG IGG ITC J5H K9- M0R M0T M1P M2O M2P M2Q N4W NAPCQ NPM PEA PQQKQ PROAC PSQYO RHF S0X SJFOW UKHRP VH1 VXZ WHG X7M ZGI ZXP K9. 7X8 |
ID | FETCH-LOGICAL-c348t-49cd94c1254d05730e3999e37eebefa23148c56e91b46e39ef677bddf6164c5e3 |
ISSN | 0149-5992 1935-5548 |
IngestDate | Fri Sep 05 14:29:25 EDT 2025 Mon Jun 30 17:05:53 EDT 2025 Wed Feb 19 02:29:47 EST 2025 Tue Jul 01 04:12:03 EDT 2025 Thu Apr 24 23:01:45 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | 2020 by the American Diabetes Association. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c348t-49cd94c1254d05730e3999e37eebefa23148c56e91b46e39ef677bddf6164c5e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-1317-0896 0000-0003-0723-489X 0000-0003-3736-7909 0000-0001-8107-616X 0000-0001-6027-3084 0000-0003-4464-453X 0000-0001-9621-9231 0000-0003-2377-6357 0000-0002-2503-7534 0000-0001-6375-3622 0000-0002-7613-1408 0000-0002-8456-1678 0000-0001-7670-8062 0000-0002-8673-3859 0000-0003-4298-3554 0000-0002-4829-5915 0000-0002-5754-7635 0000-0002-8105-2384 0000-0003-3961-9321 |
OpenAccessLink | https://diabetesjournals.org/care/article-pdf/44/2/499/532040/dc200884.pdf |
PMID | 33355246 |
PQID | 2486191557 |
PQPubID | 47715 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2473418638 proquest_journals_2486191557 pubmed_primary_33355246 crossref_citationtrail_10_2337_dc20_0884 crossref_primary_10_2337_dc20_0884 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-02-01 2021-Feb 20210201 |
PublicationDateYYYYMMDD | 2021-02-01 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Alexandria |
PublicationTitle | Diabetes care |
PublicationTitleAlternate | Diabetes Care |
PublicationYear | 2021 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | Mooranian (2022031300261433700_B27) 2014; 9 Wang (2022031300261433700_B2) 2011; 17 Mooranian (2022031300261433700_B28) 2016; 44 Zhang (2022031300261433700_B29) 2016; 13 Wahlström (2022031300261433700_B4) 2016; 24 Lu (2022031300261433700_B26) 2019; 42 Guasch-Ferré (2022031300261433700_B1) 2016; 39 de Mello (2022031300261433700_B12) 2017; 7 Wang (2022031300261433700_B15) 2019; 4 Zhu (2022031300261433700_B13) 2020; 12 Lu (2022031300261433700_B16) 2018; 72 Haeusler (2022031300261433700_B8) 2013; 62 Sun (2022031300261433700_B3) 2019; 11 Bi (2022031300261433700_B21) 2014; 6 Wang (2022031300261433700_B17) 2020; 8 Devlin (2022031300261433700_B5) 2015; 11 Vaquero (2022031300261433700_B32) 2013; 86 Thomas (2022031300261433700_B24) 2008; 7 Gu (2022031300261433700_B23) 2017; 8 Heuman (2022031300261433700_B25) 1989; 30 Makishima (2022031300261433700_B33) 1999; 284 Jia (2022031300261433700_B6) 2018; 15 Fall (2022031300261433700_B11) 2016; 59 Parsons (2022031300261433700_B18) Chávez-Talavera (2022031300261433700_B7) 2017; 152 Lloyd-Jones (2022031300261433700_B20) 2010; 121 Nowak (2022031300261433700_B9) 2016; 12 Hansen (2022031300261433700_B30) 2016; 18 Wewalka (2022031300261433700_B10) 2014; 99 Fisher (2022031300261433700_B31) 2007; 51 Lu (2022031300261433700_B14) 2019; 42 Liu (2022031300261433700_B22) 2017; 23 Craig (2022031300261433700_B19) 2003; 35 |
References_xml | – volume: 23 start-page: 859 year: 2017 ident: 2022031300261433700_B22 article-title: Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention publication-title: Nat Med doi: 10.1038/nm.4358 – volume: 13 start-page: 2135 year: 2016 ident: 2022031300261433700_B29 article-title: Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model publication-title: Mol Med Rep doi: 10.3892/mmr.2016.4761 – volume: 11 start-page: 685 year: 2015 ident: 2022031300261433700_B5 article-title: A biosynthetic pathway for a prominent class of microbiota-derived bile acids publication-title: Nat Chem Biol doi: 10.1038/nchembio.1864 – volume: 62 start-page: 4184 year: 2013 ident: 2022031300261433700_B8 article-title: Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids publication-title: Diabetes doi: 10.2337/db13-0639 – volume: 4 start-page: 874 year: 2019 ident: 2022031300261433700_B15 article-title: Ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2019.2499 – volume: 42 start-page: 2117 year: 2019 ident: 2022031300261433700_B26 article-title: High-coverage targeted lipidomics reveals novel serum lipid predictors and lipid pathway dysregulation antecedent to type 2 diabetes onset in normoglycemic Chinese adults publication-title: Diabetes Care doi: 10.2337/dc19-0100 – volume: 17 start-page: 448 year: 2011 ident: 2022031300261433700_B2 article-title: Metabolite profiles and the risk of developing diabetes publication-title: Nat Med doi: 10.1038/nm.2307 – volume: 24 start-page: 41 year: 2016 ident: 2022031300261433700_B4 article-title: Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism publication-title: Cell Metab doi: 10.1016/j.cmet.2016.05.005 – volume: 9 start-page: 150 year: 2014 ident: 2022031300261433700_B27 article-title: Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics publication-title: J Pharm Innov doi: 10.1007/s12247-014-9182-5 – volume: 99 start-page: 1442 year: 2014 ident: 2022031300261433700_B10 article-title: Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2013-3367 – volume: 11 start-page: 280 year: 2019 ident: 2022031300261433700_B3 article-title: Linking of metabolomic biomarkers with cardiometabolic health in Chinese population publication-title: J Diabetes doi: 10.1111/1753-0407.12858 – volume: 35 start-page: 1381 year: 2003 ident: 2022031300261433700_B19 article-title: International physical activity questionnaire: 12-country reliability and validity publication-title: Med Sci Sports Exerc doi: 10.1249/01.MSS.0000078924.61453.FB – volume: 18 start-page: 571 year: 2016 ident: 2022031300261433700_B30 article-title: Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion publication-title: Diabetes Obes Metab doi: 10.1111/dom.12648 – volume: 8 start-page: 115 year: 2020 ident: 2022031300261433700_B17 article-title: Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(19)30425-5 – volume: 39 start-page: 833 year: 2016 ident: 2022031300261433700_B1 article-title: Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis publication-title: Diabetes Care doi: 10.2337/dc15-2251 – ident: 2022031300261433700_B18 – volume: 51 start-page: 185 year: 2007 ident: 2022031300261433700_B31 article-title: Candidate gene association study of type 2 diabetes in a nested case-control study of the EPIC-Potsdam cohort -- role of fat assimilation publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.200600162 – volume: 152 start-page: 1679 year: 2017 ident: 2022031300261433700_B7 article-title: Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.01.055 – volume: 59 start-page: 2114 year: 2016 ident: 2022031300261433700_B11 article-title: Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes publication-title: Diabetologia doi: 10.1007/s00125-016-4041-1 – volume: 7 start-page: 46337 year: 2017 ident: 2022031300261433700_B12 article-title: Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study publication-title: Sci Rep doi: 10.1038/srep46337 – volume: 284 start-page: 1362 year: 1999 ident: 2022031300261433700_B33 article-title: Identification of a nuclear receptor for bile acids publication-title: Science doi: 10.1126/science.284.5418.1362 – volume: 121 start-page: 586 year: 2010 ident: 2022031300261433700_B20 article-title: Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192703 – volume: 42 start-page: 1539 year: 2019 ident: 2022031300261433700_B14 article-title: Predictive value of fasting glucose, postload glucose, and hemoglobin A1c on risk of diabetes and complications in Chinese adults publication-title: Diabetes Care doi: 10.2337/dc18-1390 – volume: 12 start-page: 616 year: 2020 ident: 2022031300261433700_B13 article-title: Serum total bile acids associate with risk of incident type 2 diabetes and longitudinal changes in glucose-related metabolic traits publication-title: J Diabetes doi: 10.1111/1753-0407.13040 – volume: 72 start-page: 3224 year: 2018 ident: 2022031300261433700_B16 article-title: Associations of hemoglobin A1c with cardiovascular disease and mortality in Chinese adults with diabetes publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2018.09.062 – volume: 30 start-page: 719 year: 1989 ident: 2022031300261433700_B25 article-title: Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)38331-0 – volume: 44 start-page: 1642 year: 2016 ident: 2022031300261433700_B28 article-title: Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: formulation characterization and effects on production of insulin and inflammation in a pancreatic β-cell line publication-title: Artif Cells Nanomed Biotechnol doi: 10.3109/21691401.2015.1069299 – volume: 6 start-page: 147 year: 2014 ident: 2022031300261433700_B21 article-title: Cohort profile: risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study publication-title: J Diabetes doi: 10.1111/1753-0407.12108 – volume: 8 start-page: 1785 year: 2017 ident: 2022031300261433700_B23 article-title: Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment publication-title: Nat Commun doi: 10.1038/s41467-017-01682-2 – volume: 12 start-page: e1006379 year: 2016 ident: 2022031300261433700_B9 article-title: Effect of insulin resistance on monounsaturated fatty acid levels: a multi-cohort non-targeted metabolomics and Mendelian randomization study publication-title: PLoS Genet doi: 10.1371/journal.pgen.1006379 – volume: 7 start-page: 678 year: 2008 ident: 2022031300261433700_B24 article-title: Targeting bile-acid signalling for metabolic diseases publication-title: Nat Rev Drug Discov doi: 10.1038/nrd2619 – volume: 86 start-page: 926 year: 2013 ident: 2022031300261433700_B32 article-title: Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2013.07.022 – volume: 15 start-page: 111 year: 2018 ident: 2022031300261433700_B6 article-title: Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2017.119 |
SSID | ssj0004488 |
Score | 2.571944 |
Snippet | Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA profile and... OBJECTIVE Comprehensive assessment of serum bile acids (BAs) aberrations before diabetes onset remains inconclusive. We examined the association of serum BA... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 499 |
SubjectTerms | Acids Adults Bile Bile acids Chenodeoxycholic acid Cholesterol Cholic acid Correlation analysis Deoxycholic acid Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Glucose Health risks High density lipoprotein Insulin Metabolism Network analysis Pathogenesis Regression analysis Research design Risk Taurocholic acid Tauroursodeoxycholic acid |
Title | Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33355246 https://www.proquest.com/docview/2486191557 https://www.proquest.com/docview/2473418638 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9NAFB7qCuKLeN_qKkfxQSjRbTJJGt9qu3XR3YrSQvEldCaTbqGmsm2Q-hP8H_5Pz5mZ3KTC6ksYJumk5PvmzDkz58LYi9BPvYjPAwdNBe7wlIeO8HxFrYQCP3tRQNHI5-PgdMrfz_xZq_Wz5rWUb8Ur-WNvXMn_oIp9iCtFyf4DsuWg2IFtxBeviDBer4Rx7dvq4BN1mX_tvMV53unLZbKhKADKu2QiAlDV-z7fdYY7XBQXtmgXCgXahkWqfLYu5sMqiGpYbMv2dUGiMWq368VqJ7U7PdXdVpTUhPJ3aLe60VIHyGxQF7YRK3yg3RQbB8floORyVnoD5ZpMS7VaVhv8dh_7IsfWLq-5Di2Nu3_V826u93u_XKhskdluu5Hhdgvf51L2Rp7voHZjxLHa02cFtkkYaYnp1qQvN7WW_lwVXE_nFUikS657piJdM_P2-GM8mp6dxZOT2eQau-6GoT7y__Cplnme6xqm5R8yWapo6NflwE3d5i8Gi1ZcJrfZLWtxQN_Q5w5rqewuu3FufSrusV81FsE6Bc0iIBaBZhFYFgGyCCyLoMEiIBYBIg7EIhqjYhEUgINmETRYBJZFYFj0BgoOAXFIj8gHoDl0n01HJ5PBqWOLdzgSp_jW4ZFMIi5Rf-YJJd08VqgKR8oLFYqNdI5mBe9JP1BRV_AA76k0CEORJGmABrz0lfeAHWTrTB0y8KUQIZce5crjqDGLRLhcCh4dC1wiI7fNXhafPZY2sz0VWFnFaOESQjEhFBNCbfa8fPSbSeey76GjArvYzvZN7PJe0KViCmGbPStvoyymA7Z5ptY5PROiUtjDJa3NHhrMy7d4Hmr2Lg8eXeHXj9nNaoIcsYPtZa6eoO67FU81KX8D-qqyPg |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+Serum+Bile+Acids+Profile+and+Pathway+Dysregulation+With+the+Risk+of+Developing+Diabetes+Among+Normoglycemic+Chinese+Adults%3A+Findings+From+the+4C+Study&rft.jtitle=Diabetes+care&rft.au=Lu%2C+Jieli&rft.au=Wang%2C+Shuangyuan&rft.au=Li%2C+Mian&rft.au=Gao%2C+Zhengnan&rft.date=2021-02-01&rft.issn=1935-5548&rft.eissn=1935-5548&rft.volume=44&rft.issue=2&rft.spage=499&rft_id=info:doi/10.2337%2Fdc20-0884&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |